V64M (p.Val64Met) variant of CYP51A1 (Lanosterol 14-alpha demethylase)
V64M (p.Val64Met) in CYP51A1 (Lanosterol 14-alpha demethylase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes structural context.
V64M (p.Val64Met) variant details
- p.Val64Met
- rs1194909981
- NCI-TCGA Cosmic COSV9913
- TOPMed rs1194909981
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.268
- AlphaMissense 0.10
- MetaLR 0.12
- MetaSVM -1.00
- SIFT 0.09
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available